Explore the complete record of transactions filed by Schwarzer Fred, Chief Executive Officer. Director active across 1 companies, notably IGM Biosciences, Inc.. Aggregated, 9 reports have been published. Total volume traded: €22k. The latest transaction was disclosed on 24 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Fred Schwarzer is the CEO and President of IGM Biosciences, Inc. He leads the company's operations and strategy, ensuring its growth and profitability. His experience in the biopharmaceutical sector is a valuable asset.